Trial Profile
Efficacy and safety of prolonged-release fampridine in patients with multiple sclerosis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Fampridine (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 05 Dec 2015 New trial record